Erythropoietin: When liability becomes asset in neurovascular repair

Academic Article

Abstract

  • Erythropoietin (Epo) leads to the proliferation and differentiation of erythroid precursors, but is also involved in diverse nonhematopoietic biological functions. In this issue of the JCI, Chen, Smith, and colleagues demonstrate that the temporal expression of Epo is critical for determining whether physiological or pathological repair occurs following neurovascular retinal injury in the oxygen-induced retinopathy neonatal mouse model (see the related article beginning on page 526). The pleiotrophic properties of Epo make it a likely novel therapy for treatment of neurovascular damage, but the timing of its use must be carefully considered to prevent untoward effects.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Author List

  • Grant MB; Boulton ME; Ljubimov AV
  • Start Page

  • 467
  • End Page

  • 470
  • Volume

  • 118
  • Issue

  • 2